Literature DB >> 9116648

The protective role of endogenous cytokines in host resistance against an intragastric infection with Listeria monocytogenes in mice.

S Nishikawa1, T Miura, S Sasaki, A Nakane.   

Abstract

It has been demonstrated that endogenous cytokines including gamma-interferon (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) play a protective role but that IL-4 plays a detrimental role in systemic Listeria monocytogenes infection in mice. The diverse roles of IL-10 have been reported in antilisterial resistance. In this paper, we studied the role of endogenous cytokines in host resistance against an intragastric infection with L. monocytogenes in mice. The expression of cytokine mRNAs including IFN-gamma, TNF-alpha, IL-4, IL-6, or IL-10, which were amplified by reverse transcription-PCR, was observed in intestinal intraepithelial lymphocytes irrespective of L. monocytogenes infection. Increased numbers of L. monocytogenes were detected in the ileal contents of infected mice which received monoclonal antibodies (mAbs) against IFN-gamma, TNF-alpha, IL-4, IL-6, or IL-10. By contrast, mAbs against IL-4 or IL-6 showed little effect on the growth of L. monocytogenes in the mesenteric lymph nodes (MLNs), spleen, and liver, but anti-IFN-gamma mAb and anti-TNF-alpha mAb suppressed the defense in these organs. Anti-IL-10 mAb enhanced bacterial elimination from the MLNs but not from the spleen or liver. These results suggest that the role of endogenous cytokines may differ between systemic and intestinal defenses.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9116648     DOI: 10.1111/j.1574-695X.1996.tb00148.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  7 in total

1.  Roles for tumor necrosis factor and gamma interferon in resistance to enteric listeriosis.

Authors:  G R Beretich; P B Carter; E A Havell
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Disruption of the genes for ClpXP protease in Salmonella enterica serovar Typhimurium results in persistent infection in mice, and development of persistence requires endogenous gamma interferon and tumor necrosis factor alpha.

Authors:  T Yamamoto; H Sashinami; A Takaya; T Tomoyasu; H Matsui; Y Kikuchi; T Hanawa; S Kamiya; A Nakane
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

3.  Monoassociation with probiotic Lactobacillus delbrueckii UFV-H2b20 stimulates the immune system and protects germfree mice against Listeria monocytogenes infection.

Authors:  Liliane Martins dos Santos; Mônica Morais Santos; Humberto Pereira de Souza Silva; Rosa Maria Esteves Arantes; Jacques Robert Nicoli; Leda Quercia Vieira
Journal:  Med Microbiol Immunol       Date:  2010-09-14       Impact factor: 3.402

4.  Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope.

Authors:  Hélène Saklani-Jusforgues; Elisabeth Fontan; Neirouz Soussi; Geneviève Milon; Pierre L Goossens
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

5.  Comparison of host resistance to primary and secondary Listeria monocytogenes infections in mice by intranasal and intravenous routes.

Authors:  Mayuko Mizuki; Akio Nakane; Kenji Sekikawa; Yoh-ich Tagawa; Yoichiro Iwakura
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

6.  Intestinal P glycoprotein acts as a natural defense mechanism against Listeria monocytogenes.

Authors:  Brien L Neudeck; Jennifer M Loeb; Nancy G Faith; Charles J Czuprynski
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

7.  Functional Antibodies and Innate Immune Responses to WRSS1, a Live Oral Shigella sonnei Vaccine Candidate, in Bangladeshi Adults and Children.

Authors:  Protim Sarker; Akhirunnesa Mily; Anjuman Ara; Farjana Haque; Nicole Maier; Thomas F Wierzba; Richard I Walker; Malabi M Venkatesan; Rubhana Raqib
Journal:  J Infect Dis       Date:  2021-12-20       Impact factor: 5.226

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.